SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Scott’s Liquid Gold – Inc. – ‘10-Q’ for 9/30/23

On:  Tuesday, 11/7/23, at 4:05pm ET   ·   For:  9/30/23   ·   Accession #:  950170-23-60223   ·   File #:  1-13458

Previous ‘10-Q’:  ‘10-Q’ on 8/14/23 for 6/30/23   ·   Next & Latest:  ‘10-Q’ on 5/8/24 for 3/31/24   ·   1 Reference:  By:  Scott’s Liquid Gold – Inc. – ‘10-K’ on 3/26/24 for 12/31/23

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

11/07/23  Scott’s Liquid Gold - Inc.        10-Q        9/30/23   59:8.8M                                   Donnelley … Solutions/FA

Quarterly Report   —   Form 10-Q

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-Q        Quarterly Report                                    HTML   2.04M 
 2: EX-10.1     Material Contract                                   HTML    441K 
 3: EX-31.1     Certification -- §302 - SOA'02                      HTML     22K 
 4: EX-31.2     Certification -- §302 - SOA'02                      HTML     22K 
 5: EX-32.1     Certification -- §906 - SOA'02                      HTML     20K 
11: R1          Document and Entity Information                     HTML     67K 
12: R2          Condensed Consolidated Statements of Operations     HTML    129K 
13: R3          Condensed Consolidated Balance Sheets               HTML    113K 
14: R4          Condensed Consolidated Balance Sheets               HTML     39K 
                (Parenthetical)                                                  
15: R5          Condensed Consolidated Statements of Shareholders'  HTML     66K 
                Equity                                                           
16: R6          Condensed Consolidated Statements of Cash Flows     HTML     90K 
17: R7          Organization and Summary of Significant Accounting  HTML     97K 
                Policies                                                         
18: R8          Liquidity                                           HTML     23K 
19: R9          Divestitures                                        HTML    581K 
20: R10         Stock-Based Compensation                            HTML     29K 
21: R11         Earnings Per Share                                  HTML     69K 
22: R12         Segment Information                                 HTML     26K 
23: R13         Intangible Assets                                   HTML     51K 
24: R14         Long-Term Debt                                      HTML     35K 
25: R15         Leases                                              HTML     74K 
26: R16         Subsequent Events                                   HTML     22K 
27: R17         Organization and Summary of Significant Accounting  HTML    136K 
                Policies (Policies)                                              
28: R18         Organization and Summary of Significant Accounting  HTML     45K 
                Policies (Tables)                                                
29: R19         Divestitures (Tables)                               HTML    554K 
30: R20         Earnings Per Share (Tables)                         HTML     69K 
31: R21         Intangible Assets (Tables)                          HTML     51K 
32: R22         Leases (Tables)                                     HTML     75K 
33: R23         Organization and Summary of Significant Accounting  HTML     25K 
                Policies - Additional Information (Details)                      
34: R24         Organization and Summary of Significant Accounting  HTML     28K 
                Policies - Schedule of Cash and Cash Equivalents                 
                (Details)                                                        
35: R25         Organization and Summary of Significant Accounting  HTML     34K 
                Policies - Additional Information 1 (Details)                    
36: R26         Organization and Summary of Significant Accounting  HTML     25K 
                Policies - Summary of Customer Allowances for                    
                Trade Promotions and Allowance for Doubtful                      
                Accounts (Details)                                               
37: R27         Organization and Summary of Significant Accounting  HTML     25K 
                Policies - Additional Information 2 (Details)                    
38: R28         Liquidity - Additional Information (Details)        HTML     24K 
39: R29         Divestitures - Additional Information (Details)     HTML     78K 
40: R30         Divestitures - Summary of Financial Information     HTML     90K 
                Constituting Pretax Loss to After-Tax Loss of                    
                Discontinued Operations (Details)                                
41: R31         Divestitures - Summary of Financial Information     HTML     54K 
                Constituting Major Classes of Assets of                          
                Discontinued Operations (Details)                                
42: R32         Divestitures - Summary of Carrying Value of Assets  HTML     54K 
                and Resulting in Gain on Sale of Discontinued                    
                Operations (Details)                                             
43: R33         Stock-Based Compensation - Additional Information   HTML     55K 
                (Details)                                                        
44: R34         Earnings Per Share - Reconciliation of the          HTML     30K 
                Weighted Average Number of Common Shares                         
                Outstanding (Details)                                            
45: R35         Earnings Per Share - Common Stock Equivalents       HTML     24K 
                Excluded From the Calculation of Earnings Per                    
                Share (Details)                                                  
46: R36         Segment Information - Additional Information        HTML     23K 
                (Details)                                                        
47: R37         Intangible Assets - Schedule of Intangible Assets   HTML     27K 
                (Details)                                                        
48: R38         Intangible Assets - Additional Information          HTML     20K 
                (Details)                                                        
49: R39         Intangible Assets - Schedule of Estimated           HTML     31K 
                Amortization Expense (Details)                                   
50: R40         Long-Term Debt - Additional Information (Details)   HTML     77K 
51: R41         Leases - Additional Information (Details)           HTML     22K 
52: R42         Leases - Schedule of Information Related to Leases  HTML     28K 
                (Details)                                                        
53: R43         Leases - Schedule of Future Minimum Annual Lease    HTML     37K 
                Payments (Details)                                               
54: R44         Subsequent Events - Additional Information          HTML     23K 
                (Details)                                                        
57: XML         IDEA XML File -- Filing Summary                      XML    103K 
55: XML         XBRL Instance -- slgd-20230930_htm                   XML   2.31M 
56: EXCEL       IDEA Workbook of Financial Report Info              XLSX    103K 
 6: EX-101.CAL  XBRL Calculations -- slgd-20230930_cal               XML    148K 
 9: EX-101.DEF  XBRL Definitions -- slgd-20230930_def                XML    343K 
 7: EX-101.LAB  XBRL Labels -- slgd-20230930_lab                     XML    865K 
 8: EX-101.PRE  XBRL Presentations -- slgd-20230930_pre              XML    638K 
10: EX-101.SCH  XBRL Schema -- slgd-20230930                         XSD    118K 
58: JSON        XBRL Instance as JSON Data -- MetaLinks              335±   528K 
59: ZIP         XBRL Zipped Folder -- 0000950170-23-060223-xbrl      Zip    269K 


‘10-Q’   —   Quarterly Report

Document Table of Contents

Page (sequential)   (alphabetic) Top
 
11st Page  –  Filing Submission
"Part I
"Financial Statements
"Management's Discussion and Analysis of Financial Condition and Results of Operations
"Controls and Procedures
"Part Ii
"Risk Factors
"Exhibits

This is an HTML Document rendered as filed.  [ Alternative Formats ]



 iX:   C:  C: 
  10-Q  
 i --12-31 i Q3 i 0000088000 i false i  i 0000088000slgd:SellingExpenseMember2023-07-012023-09-300000088000us-gaap:RestrictedStockUnitsRSUMember2023-01-012023-09-300000088000us-gaap:CommonStockMember2022-01-012022-03-310000088000slgd:LoanAndSecurityAgreementMemberslgd:TermLoanMemberslgd:LaPlataCapitalLLCMember2023-09-300000088000us-gaap:RetainedEarningsMember2023-07-012023-09-300000088000us-gaap:DiscontinuedOperationsDisposedOfBySaleMemberslgd:PrellMember2023-09-300000088000slgd:LoanAndSecurityAgreementMemberslgd:TermLoanMemberslgd:LaPlataCapitalLLCMember2022-01-012022-03-310000088000us-gaap:DiscontinuedOperationsDisposedOfBySaleMemberslgd:BIZMember2023-01-012023-09-300000088000us-gaap:EmployeeStockOptionMember2022-01-012022-09-300000088000slgd:ScottsLiquidGoldMember2023-09-300000088000us-gaap:RetainedEarningsMember2023-03-310000088000us-gaap:CommonStockMember2023-09-300000088000us-gaap:DiscontinuedOperationsDisposedOfBySaleMemberslgd:AlphaMember2023-01-012023-09-300000088000slgd:BIZMember2023-01-012023-09-300000088000us-gaap:NoncompeteAgreementsMember2023-09-300000088000us-gaap:RetainedEarningsMember2023-06-300000088000us-gaap:DiscontinuedOperationsDisposedOfBySaleMemberslgd:BIZMember2022-01-012022-09-300000088000us-gaap:RetainedEarningsMember2023-09-300000088000us-gaap:AdditionalPaidInCapitalMember2022-06-300000088000us-gaap:RevolvingCreditFacilityMemberslgd:UMBBankNAMemberslgd:ConsentAndSeventhAmendmentToLoanAndSecurityAgreementMember2023-01-012023-09-300000088000us-gaap:RetainedEarningsMember2022-01-012022-03-310000088000us-gaap:AdditionalPaidInCapitalMember2022-07-012022-09-300000088000us-gaap:CommonStockMember2021-12-310000088000us-gaap:DiscontinuedOperationsDisposedOfBySaleMemberslgd:AlphaMember2022-01-012022-09-300000088000us-gaap:AdditionalPaidInCapitalMember2023-07-012023-09-300000088000us-gaap:DiscontinuedOperationsDisposedOfBySaleMemberslgd:AlphaMember2022-12-310000088000us-gaap:CommonStockMember2022-06-300000088000slgd:FormulasMemberslgd:NeotericMember2023-09-300000088000slgd:NeotericBeautyHoldingsLlcMember2023-09-152023-09-1500000880002022-01-012022-03-3100000880002023-06-300000088000slgd:LoanAndSecurityAgreementMemberslgd:TermLoanMemberslgd:UMBBankNAMember2020-07-010000088000us-gaap:DiscontinuedOperationsDisposedOfBySaleMemberslgd:AlphaMember2023-09-300000088000slgd:ScottsLiquidGoldMember2023-01-012023-09-300000088000us-gaap:CommonStockMember2023-04-012023-06-300000088000us-gaap:RevolvingCreditFacilityMemberslgd:UMBBankNAMemberslgd:ConsentAndSeventhAmendmentToLoanAndSecurityAgreementMember2023-01-232023-01-230000088000us-gaap:AdditionalPaidInCapitalMember2023-03-310000088000us-gaap:RetainedEarningsMember2022-12-310000088000slgd:LoanAndSecurityAgreementMemberslgd:TermLoanMemberslgd:UMBBankNAMember2020-07-012020-07-010000088000slgd:FormulasMember2023-09-300000088000us-gaap:RestrictedStockUnitsRSUMember2023-07-012023-09-300000088000us-gaap:DiscontinuedOperationsDisposedOfBySaleMemberslgd:ScottsLiquidGoldMember2022-01-012022-09-300000088000us-gaap:RestrictedStockUnitsRSUMemberslgd:TwoThousandTwentyTwoIndividualEmployeeGrantMember2023-01-012023-09-300000088000slgd:BIZMemberslgd:FormulasMember2023-09-300000088000slgd:SellingExpenseMember2022-07-012022-09-3000000880002022-07-012022-09-300000088000us-gaap:RestrictedStockUnitsRSUMember2022-01-012022-09-300000088000us-gaap:DiscontinuedOperationsDisposedOfBySaleMember2023-01-012023-09-300000088000us-gaap:RestrictedStockUnitsRSUMember2023-01-012023-09-300000088000slgd:ScottsLiquidGoldMemberus-gaap:DiscontinuedOperationsDisposedOfBySaleMember2022-07-012022-09-3000000880002023-04-012023-06-300000088000us-gaap:DiscontinuedOperationsDisposedOfBySaleMemberslgd:AlphaMember2023-07-012023-07-310000088000us-gaap:AdditionalPaidInCapitalMember2022-04-012022-06-300000088000us-gaap:DiscontinuedOperationsDisposedOfBySaleMemberslgd:PrellMember2022-01-012022-09-300000088000us-gaap:AdditionalPaidInCapitalMember2021-12-310000088000us-gaap:DiscontinuedOperationsDisposedOfBySaleMemberslgd:ScottsLiquidGoldMember2023-09-300000088000us-gaap:DiscontinuedOperationsDisposedOfBySaleMemberslgd:NeotericMember2023-07-012023-09-300000088000us-gaap:RevolvingCreditFacilityMemberslgd:LoanAndSecurityAgreementMemberslgd:UMBBankNAMemberslgd:FloorRateMember2022-08-102022-08-100000088000slgd:AlphaMember2023-01-012023-09-3000000880002022-01-012022-09-300000088000slgd:TermLoanTwoMemberslgd:LoanAndSecurityAgreementMemberslgd:LaPlataCapitalLLCMember2021-11-090000088000slgd:NeotericMember2023-09-300000088000us-gaap:RevolvingCreditFacilityMemberslgd:LoanAndSecurityAgreementMemberus-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberslgd:UMBBankNAMember2022-08-102022-08-100000088000us-gaap:DiscontinuedOperationsDisposedOfBySaleMemberslgd:PrellMember2022-12-152022-12-150000088000us-gaap:DiscontinuedOperationsDisposedOfBySaleMemberslgd:NeotericAlphaBizPrellAndScottsLiquidGoldMember2023-07-012023-09-3000000880002023-07-012023-07-310000088000us-gaap:AdditionalPaidInCapitalMember2023-09-300000088000us-gaap:DiscontinuedOperationsDisposedOfBySaleMemberslgd:BIZMember2023-09-300000088000slgd:InternalUseSoftwareMember2023-09-300000088000us-gaap:CommonStockMember2022-09-300000088000us-gaap:TradeNamesMember2023-09-300000088000us-gaap:DiscontinuedOperationsDisposedOfBySaleMemberslgd:PrellMember2022-12-150000088000us-gaap:AdditionalPaidInCapitalMember2022-03-310000088000us-gaap:DiscontinuedOperationsDisposedOfBySaleMemberslgd:BIZMember2022-12-310000088000slgd:NeotericMemberus-gaap:TradeNamesMember2023-09-300000088000us-gaap:AdditionalPaidInCapitalMember2023-04-012023-06-300000088000slgd:LoanAndSecurityAgreementMemberslgd:TermLoanMemberslgd:LaPlataCapitalLLCMember2023-01-012023-09-300000088000slgd:BIZMember2023-07-012023-07-3100000880002023-11-0600000880002023-09-300000088000us-gaap:RevolvingCreditFacilityMemberslgd:LoanAndSecurityAgreementMemberus-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberslgd:UMBBankNAMember2023-01-012023-09-300000088000us-gaap:DiscontinuedOperationsDisposedOfBySaleMemberslgd:BIZMember2022-07-012022-09-300000088000slgd:MaranCapitalManagementLlcMemberus-gaap:SubsequentEventMember2023-10-012023-10-310000088000us-gaap:RetainedEarningsMember2022-09-300000088000us-gaap:RestrictedStockUnitsRSUMember2022-01-012022-09-300000088000us-gaap:DiscontinuedOperationsDisposedOfBySaleMemberslgd:NeotericMember2022-07-012022-09-300000088000us-gaap:DiscontinuedOperationsDisposedOfBySaleMember2022-07-012022-09-3000000880002023-01-012023-09-300000088000slgd:AlphaMember2023-09-300000088000us-gaap:RestrictedStockUnitsRSUMember2023-09-300000088000us-gaap:DiscontinuedOperationsDisposedOfBySaleMemberslgd:PrellMember2022-07-012022-09-3000000880002023-03-310000088000us-gaap:DiscontinuedOperationsDisposedOfBySaleMemberslgd:AlphaMember2022-07-012022-09-300000088000slgd:NeotericBeautyHoldingsLlcMember2023-01-012023-09-300000088000us-gaap:ShareBasedCompensationAwardTrancheTwoMemberus-gaap:RestrictedStockUnitsRSUMemberslgd:TwoThousandTwentyTwoIndividualExecutiveGrantMember2023-05-112023-05-110000088000us-gaap:RevolvingCreditFacilityMemberslgd:UMBBankNAMemberslgd:ConsentAndSeventhAmendmentToLoanAndSecurityAgreementMember2023-09-300000088000us-gaap:RevolvingCreditFacilityMemberslgd:UMBBankNAMemberslgd:ConsentAndSeventhAmendmentToLoanAndSecurityAgreementMember2022-01-012022-09-300000088000us-gaap:CommonStockMember2023-06-300000088000us-gaap:DiscontinuedOperationsDisposedOfBySaleMemberslgd:PrellMember2022-12-310000088000us-gaap:RetainedEarningsMember2021-12-310000088000us-gaap:DiscontinuedOperationsDisposedOfBySaleMember2022-12-310000088000srt:MaximumMember2023-09-300000088000us-gaap:RetainedEarningsMember2023-04-012023-06-3000000880002021-12-310000088000us-gaap:RestrictedStockUnitsRSUMember2022-07-012022-09-3000000880002022-12-3100000880002022-04-012022-06-300000088000slgd:BIZMemberus-gaap:TradeNamesMember2023-09-300000088000slgd:AlphaMember2023-07-012023-07-3100000880002022-09-300000088000slgd:NeotericBeautyHoldingsLlcMember2023-09-150000088000slgd:SellingExpenseMember2022-01-012022-09-300000088000us-gaap:CommonStockMember2022-03-310000088000us-gaap:RevolvingCreditFacilityMembersrt:MaximumMemberslgd:LoanAndSecurityAgreementMemberslgd:UMBBankNAMember2022-08-100000088000slgd:InternalUseSoftwareCostsMember2023-09-300000088000us-gaap:ShareBasedCompensationAwardTrancheTwoMemberus-gaap:RestrictedStockUnitsRSUMemberslgd:TwoThousandTwentyTwoIndividualExecutiveGrantMember2022-03-022022-03-020000088000slgd:BIZMember2023-09-300000088000us-gaap:CommonStockMember2022-12-310000088000us-gaap:DiscontinuedOperationsDisposedOfBySaleMemberslgd:AlphaMember2023-07-012023-09-300000088000us-gaap:AdditionalPaidInCapitalMember2022-09-3000000880002022-06-300000088000us-gaap:AdditionalPaidInCapitalMember2023-01-012023-03-310000088000us-gaap:DiscontinuedOperationsDisposedOfBySaleMemberslgd:NeotericMember2022-12-310000088000slgd:InternalUseSoftwareMember2022-12-310000088000us-gaap:EmployeeStockOptionMember2023-01-012023-09-300000088000us-gaap:RetainedEarningsMember2023-01-012023-03-310000088000us-gaap:DiscontinuedOperationsDisposedOfBySaleMember2022-01-012022-09-300000088000us-gaap:AdditionalPaidInCapitalMember2023-06-300000088000us-gaap:CommonStockMember2023-03-310000088000us-gaap:RetainedEarningsMember2022-06-300000088000us-gaap:RestrictedStockUnitsRSUMemberslgd:TwoThousandTwentyTwoIndividualEmployeeGrantMember2022-01-182022-01-180000088000us-gaap:DiscontinuedOperationsDisposedOfBySaleMemberslgd:AlphaMember2023-08-012023-08-3100000880002022-03-310000088000us-gaap:DiscontinuedOperationsDisposedOfBySaleMemberslgd:ScottsLiquidGoldMember2023-01-230000088000us-gaap:DiscontinuedOperationsDisposedOfBySaleMemberslgd:BIZMember2023-07-012023-09-300000088000us-gaap:AdditionalPaidInCapitalMember2022-01-012022-03-310000088000us-gaap:DiscontinuedOperationsDisposedOfBySaleMemberslgd:ScottsLiquidGoldMember2023-01-012023-09-300000088000us-gaap:DiscontinuedOperationsDisposedOfBySaleMemberslgd:ScottsLiquidGoldMember2023-01-232023-01-230000088000us-gaap:RetainedEarningsMember2022-03-310000088000slgd:BIZMemberus-gaap:NoncompeteAgreementsMember2023-09-300000088000us-gaap:DiscontinuedOperationsDisposedOfBySaleMemberslgd:NeotericMember2023-01-012023-09-300000088000us-gaap:DiscontinuedOperationsDisposedOfBySaleMemberslgd:ScottsLiquidGoldMember2022-12-310000088000us-gaap:RevolvingCreditFacilityMemberslgd:UMBBankNAMemberslgd:ConsentAndSeventhAmendmentToLoanAndSecurityAgreementMember2022-12-310000088000slgd:SellingExpenseMember2023-01-012023-09-300000088000slgd:LoanAndSecurityAgreementMemberslgd:TermLoanMemberslgd:LaPlataCapitalLLCMember2022-01-012022-09-300000088000us-gaap:RetainedEarningsMember2022-04-012022-06-300000088000us-gaap:RetainedEarningsMember2022-07-012022-09-300000088000us-gaap:DiscontinuedOperationsDisposedOfBySaleMember2023-07-012023-09-300000088000slgd:NeotericMember2023-01-012023-09-3000000880002023-01-012023-03-310000088000us-gaap:AdditionalPaidInCapitalMember2022-12-3100000880002023-07-012023-09-300000088000us-gaap:DiscontinuedOperationsDisposedOfBySaleMemberslgd:NeotericMember2022-01-012022-09-300000088000slgd:LoanAndSecurityAgreementMemberslgd:TermLoanMemberslgd:LaPlataCapitalLLCMember2022-12-310000088000slgd:LoanAndSecurityAgreementMemberslgd:TermLoanMemberslgd:LaPlataCapitalLLCMember2021-11-09slgd:Segmentxbrli:purexbrli:sharesslgd:Daysiso4217:USDxbrli:sharesiso4217:USD

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM  i 10-Q

(Mark One)

 i  QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended i  September 30,  i 2023 / 

OR

 i  TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from to

Commission File Number:  i 001-13458

 i SCOTT’S LIQUID GOLD-INC.

(Exact name of registrant as specified in its charter)

 i Colorado

 i 84-0920811

(State or other jurisdiction of
incorporation or organization)

(I.R.S. Employer
Identification No.)

 i 8400 E. Crescent Parkway,  i Suite 450,  i Greenwood Village,  i CO

 i 80111

(Address of principal executive offices)

(Zip Code)

Registrant’s telephone number, including area code:  i (303)  i 373-4860

Securities registered pursuant to Section 12(b) of the Exchange Act.

 

Title of each class

 

Trading Symbol

 

Name of exchange on which registered

None

 

None

 

None

Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.  i Yes No

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).  i Yes No

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer

Accelerated filer

 

 

 

 

 i Non-accelerated filer

Smaller reporting company

 i 

 

 

 

 

 

 

 

Emerging growth company

 

 i 

 

 

 

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes No  i 

As of November 6, 2023, the registrant had  i 12,999,790 shares of its common stock, $0.10 par value per share, outstanding.

 


 

CAUTIONARY NOTE ON FORWARD-LOOKING INFORMATION

This Quarterly Report on Form 10-Q (this “Report”) contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, in addition to historical information. All statements, other than statements of historical facts, included in this Report that address activities, events, or developments with respect to our financial condition, results of operations, or economic performance that we expect, believe, or anticipate will or may occur in the future, or that address plans and objectives of management for future operations, are forward-looking statements. You can typically identify forward-looking statements by the use of words, such as “may,” “could,” “should,” “assume,” “project,” “believe,” “anticipate,” “expect,” “estimate,” “potential,” “plan,” and other similar words. These statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995.

The forward-looking statements contained in this Report are based on management’s current expectations and are subject to uncertainty and changes in circumstances. We cannot assure you that future developments affecting us will be those that we have anticipated. Forward-looking statements and our performance inherently involve risks and uncertainties that could cause actual results to differ materially from the forward-looking statements. Factors that would cause or contribute to such differences include, but are not limited to:

disruptions or inefficiencies in the supply chain;
dependence on third-party vendors and on sales to major customers;
competition from large consumer products companies in the United States;
competitive factors, including any decrease in distribution of (i.e., retail stores carrying) our significant products;
new competitive products and/or technological changes;
the need for effective advertising of our products and limited resources available for such advertising;
unfavorable economic conditions;
changing consumer preferences and the continued acceptance of each of our significant products in the marketplace;
the degree of success of any new product or product line introduction by us;
the degree of success of the integration of product lines or businesses we may acquire;
changes in the regulation of our products, including applicable environmental, U.S. and international Food and Drug Administration regulations and process-audit compliance;
the loss of any executive officer or other personnel;
future losses which could affect our liquidity;
the risk that we may not be able to remediate the existing material weakness and develop and maintain effective internal controls over financial reporting;
other matters discussed in this Report, including the risks described in the Risk Factors section of this Report and in our Annual Report on Form 10-K for the year ended December 31, 2022 and subsequent Quarterly Reports on Form 10-Q.

We caution you that forward-looking statements are not guarantees of future performance and that actual results or performance may be materially different from those expressed or implied in the forward-looking statements. The forward-looking statements in this Report speak as of the filing date of this Report. Although we may from time to time voluntarily update our prior forward-looking statements, we undertake no obligation to revise any forward-looking statements in order to reflect events or circumstances that may arise after the date of this Report.

 

 

 


 

TABLE OF CONTENTS

Page

PART I

 

Item 1.

Financial Statements

1

Item 2.

Management’s Discussion and Analysis of Financial Condition and Results of Operations

17

Item 4.

Controls and Procedures

20

PART II

 

Item 1A.

Risk Factors

21

Item 6.

Exhibits

21

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 


 

PART I

 

ITEM 1. FINANCIAL STATEMENTS.

SCOTT’S LIQUID GOLD-INC. & SUBSIDIARIES

Condensed Consolidated Statements of Operations (Unaudited)

(in thousands, except per share data)

 

 

Three Months Ended

 

 

Nine Months Ended

 

 

September 30,

 

 

September 30,

 

 

2023

 

 

2022

 

 

2023

 

 

2022

 

Net sales

$

 i 907

 

 

$

 i 733

 

 

$

 i 2,623

 

 

$

 i 2,315

 

Cost of sales

 

 i 552

 

 

 

 i 319

 

 

 

 i 1,564

 

 

 

 i 1,255

 

Gross profit

 

 i 355

 

 

 

 i 414

 

 

 

 i 1,059

 

 

 

 i 1,060

 

 

 

 

 

 

 

 

 

 

 

Operating expenses:

 

 

 

 

 

 

 

 

 

 

 

Advertising

 

 i 89

 

 

 

 i 166

 

 

 

 i 363

 

 

 

 i 492

 

Selling

 

 i 382

 

 

 

 i 606

 

 

 

 i 1,276

 

 

 

 i 2,326

 

General and administrative

 

 i 811

 

 

 

 i 655

 

 

 

 i 2,069

 

 

 

 i 2,164

 

Intangible asset amortization

 

 i 45

 

 

 

 i 65

 

 

 

 i 135

 

 

 

 i 313

 

Impairment of goodwill and intangible assets

 

-

 

 

 

-

 

 

 

-

 

 

 

 i 3,589

 

Total operating expenses

 

 i 1,327

 

 

 

 i 1,492

 

 

 

 i 3,843

 

 

 

 i 8,884

 

Loss from operations

 

( i 972

)

 

 

( i 1,078

)

 

 

( i 2,784

)

 

 

( i 7,824

)

 

 

 

 

 

 

 

 

 

 

 

 

Interest expense

 

( i 32

)

 

 

( i 27

)

 

 

( i 145

)

 

 

( i 83

)

Interest income

 

 i 16

 

 

 

-

 

 

 

 i 16

 

 

 

-

 

Loss before income taxes and discontinued operations

 

( i 988

)

 

 

( i 1,105

)

 

 

( i 2,913

)

 

 

( i 7,907

)

Income tax expense

 

( i 4

)

 

 

( i 2

)

 

 

( i 6

)

 

 

( i 55

)

Loss from continuing operations

 

( i 992

)

 

 

( i 1,107

)

 

 

( i 2,919

)

 

 

( i 7,962

)

Income from discontinued operations, net of taxes

 

 i 3,987

 

 

 

 i 363

 

 

 

 i 5,830

 

 

 

 i 2,434

 

Net income (loss)

$

 i 2,995

 

 

$

( i 744

)

 

$

 i 2,911

 

 

$

( i 5,528

)

 

 

 

 

 

 

 

 

 

 

 

 

Basic and diluted net income (loss) per common shares:

 

 

 

 

 

 

 

 

 

 

 

Loss from continuing operations

$

( i  i 0.08 / 

)

 

$

( i  i 0.09 / 

)

 

$

( i  i 0.23 / 

)

 

$

( i  i 0.62 / 

)

Income from discontinued operations

$

 i  i 0.31 / 

 

 

$

 i  i 0.03 / 

 

 

$

 i  i 0.45 / 

 

 

$

 i  i 0.19 / 

 

Net income (loss) per common share

$

 i  i 0.23 / 

 

 

$

( i  i 0.06 / 

)

 

$

 i  i 0.22 / 

 

 

$

( i  i 0.43 / 

)

 

 

 

 

 

 

 

 

 

 

 

 

Weighted average shares outstanding:

 

 

 

 

 

 

 

 

 

 

 

Basic and diluted

 

 i  i 12,997 / 

 

 

 

 i  i 12,749 / 

 

 

 

 i  i 12,901 / 

 

 

 

 i  i 12,747 / 

 

 




 

 

 

 

 

 

 

 

 

See accompanying notes to these Condensed Consolidated Financial Statements.

1


 

SCOTT’S LIQUID GOLD-INC. & SUBSIDIARIES

Condensed Consolidated Balance Sheets (Unaudited)

(in thousands, except par value amounts)

 

 

September 30,

 

 

December 31,

 

 

2023

 

 

2022

 

Assets

 

 

 

 

 

Current assets:

 

 

 

 

 

Cash and cash equivalents

$

 i 4,415

 

 

$

 i 49

 

Restricted cash

 

 i 250

 

 

 

-

 

Accounts receivable, net

 

 i 1,083

 

 

 

 i 1,833

 

Inventories

 

 i 370

 

 

 

 i 775

 

Income taxes receivable

 

-

 

 

 

 i 239

 

Prepaid expenses

 

 i 168

 

 

 

 i 243

 

Assets of discontinued operations

 

-

 

 

 

 i 4,261

 

Total current assets

 

 i 6,286

 

 

 

 i 7,400

 

 

 

 

 

 

 

Intangible assets, net

 

 i 658

 

 

 

 i 793

 

Operating lease right-of-use assets

 

 i 2,299

 

 

 

 i 2,491

 

Other assets

 

 i 39

 

 

 

 i 47

 

Total assets

$

 i 9,282

 

 

$

 i 10,731

 

 

 

 

 

 

 

Liabilities and Shareholders’ Equity

 

 

 

 

 

Current liabilities:

 

 

 

 

 

Accounts payable

$

 i 753

 

 

$

 i 1,407

 

Accrued expenses

 

 i 132

 

 

 

 i 311

 

Current portion of long-term debt, net of debt issuance costs

 

-

 

 

 

 i 3,384

 

Operating lease liabilities, current portion

 

 i 285

 

 

 

 i 270

 

Total current liabilities

 

 i 1,170

 

 

 

 i 5,372

 

 

 

 

 

 

 

Operating lease liabilities, net of current

 

 i 2,296

 

 

 

 i 2,512

 

Other liabilities

 

 i 27

 

 

 

 i 27

 

Total liabilities

 

 i 3,493

 

 

 

 i 7,911

 

 

 

 

 

 

 

Shareholders’ equity:

 

 

 

 

 

Preferred Stock,  i  i no /  par value, authorized  i  i 20,000 /  shares;  i  i  i  i no /  /  /  shares issued and outstanding

 

-

 

 

 

-

 

Common Stock; $ i  i 0.10 /  par value, authorized  i  i 50,000 /  shares; issued and outstanding  i  i 12,997 /  shares (2023) and  i  i 12,797 /  shares (2022)

 

 i 1,300

 

 

 

 i 1,280

 

Capital in excess of par

 

 i 7,950

 

 

 

 i 7,912

 

Accumulated deficit

 

( i 3,461

)

 

 

( i 6,372

)

Total shareholders’ equity

 

 i 5,789

 

 

 

 i 2,820

 

Total liabilities and shareholders’ equity

$

 i 9,282

 

 

$

 i 10,731

 

 

 




 

 

 

 

 

 

 

 

See accompanying notes to these Condensed Consolidated Financial Statements.

2


 

SCOTT’S LIQUID GOLD-INC. & SUBSIDIARIES

 

Condensed Consolidated Statements of Shareholders’ Equity (Unaudited)

(in thousands)

 

 

Common Stock

 

 

 

 

 

 

 

 

 

 

 

Shares

 

 

Amount

 

 

Capital in Excess of Par

 

 

(Accumulated Deficit) Retained Earnings

 

 

Total

 

Balance, December 31, 2022

 

 i 12,797

 

 

$

 i 1,280

 

 

$

 i 7,912

 

 

$

( i 6,372

)

 

$

 i 2,820

 

Stock-based compensation

 

-

 

 

 

-

 

 

 

 i 7

 

 

 

-

 

 

 

 i 7

 

Net income

 

-

 

 

 

-

 

 

 

-

 

 

 

 i 369

 

 

 

 i 369

 

Balance, March 31, 2023 (Unaudited)

 

 i 12,797

 

 

 

 i 1,280

 

 

 

 i 7,919

 

 

 

( i 6,003

)

 

 

 i 3,196

 

Stock-based compensation

 

 i 200

 

 

 

 i 20

 

 

 

 i 30

 

 

 

-

 

 

 

 i 50

 

Net loss

 

-

 

 

 

-

 

 

 

-

 

 

 

( i 453

)

 

 

( i 453

)

Balance, June 30, 2023 (Unaudited)

 

 i 12,997

 

 

$

 i 1,300

 

 

$

 i 7,949

 

 

$

( i 6,456

)

 

$

 i 2,793

 

Stock-based compensation

 

-

 

 

 

-

 

 

 

 i 1

 

 

 

-

 

 

 

 i 1

 

Net income

 

-

 

 

 

-

 

 

 

-

 

 

 

 i 2,995

 

 

 

 i 2,995

 

Balance, September 30, 2023 (Unaudited)

 

 i 12,997

 

 

$

 i 1,300

 

 

$

 i 7,950

 

 

$

( i 3,461

)

 

$

 i 5,789

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balance, December 31, 2021

 

 i 12,727

 

 

$

 i 1,273

 

 

$

 i 7,789

 

 

$

 i 2,479

 

 

$

 i 11,541

 

Stock-based compensation

 

-

 

 

 

-

 

 

 

 i 35

 

 

 

-

 

 

 

 i 35

 

Net loss

 

-

 

 

 

-

 

 

 

-

 

 

 

( i 451

)

 

 

( i 451

)

Restricted stock unit vesting

 

 i 22

 

 

 

 i 2

 

 

 

 i 26

 

 

 

-

 

 

 

 i 28

 

Balance, March 31, 2022 (Unaudited)

 

 i 12,749

 

 

 

 i 1,275

 

 

 

 i 7,850

 

 

 

 i 2,028

 

 

 

 i 11,153

 

Stock-based compensation

 

-

 

 

 

-

 

 

 

 i 22

 

 

 

-

 

 

 

 i 22

 

Net loss

 

-

 

 

 

-

 

 

 

-

 

 

 

( i 4,333

)

 

 

( i 4,333

)

Balance, June 30, 2022 (Unaudited)

 

 i 12,749

 

 

$

 i 1,275

 

 

$

 i 7,872

 

 

$

( i 2,305

)

 

$

 i 6,842

 

Stock-based compensation

 

-

 

 

 

-

 

 

 

 i 28

 

 

 

-

 

 

 

 i 28

 

Net loss

 

-

 

 

 

-

 

 

 

-

 

 

 

( i 744

)

 

 

( i 744

)

Balance, September 30, 2022 (Unaudited)

 

 i 12,749

 

 

$

 i 1,275

 

 

$

 i 7,900

 

 

$

( i 3,049

)

 

$

 i 6,126

 

 

 

 

 

 

 

 

 

 

 

 

 

See accompanying notes to these Condensed Consolidated Financial Statements.

3


 

SCOTT’S LIQUID GOLD-INC. & SUBSIDIARIES

Condensed Consolidated Statements of Cash Flows (Unaudited)

(in thousands)

 

 

Nine Months Ended

 

 

September 30,

 

 

2023

 

 

2022

 

Cash flows from operating activities:

 

 

 

 

Net income (loss)

$

 i 2,911

 

 

$

( i 5,528

)

Adjustments to reconcile net income (loss) to net cash used by operating activities:

 

 

 

 

 

Depreciation and amortization

 

 i 281

 

 

 

 i 480

 

Gain on disposal of discontinued operations

 

( i 4,654

)

 

 

-

 

Stock-based compensation

 

 i 58

 

 

 

 i 113

 

Impairment of goodwill and intangible assets

 

-

 

 

 

 i 3,589

 

Change in operating assets and liabilities:

 

 

 

 

 

Accounts receivable

 

 i 915

 

 

 

 i 1,725

 

Inventories

 

 i 961

 

 

 

( i 612

)

Prepaid expenses and other assets

 

 i 84

 

 

 

 i 222

 

Income taxes receivable

 

 i 239

 

 

 

 i 73

 

Accounts payable, accrued expenses, and other liabilities

 

( i 842

)

 

 

( i 1,251

)

Total adjustments to net income (loss)

 

( i 2,958

)

 

 

 i 4,339

 

Net cash used in operating activities

 

( i 47

)

 

 

( i 1,189

)

 

 

 

 

 

 

Cash flows from investing activities:

 

 

 

Proceeds from sale of discontinued operations

 

 i 8,167

 

 

 

-

 

Purchase of software

 

-

 

 

 

( i 142

)

Net cash provided by (used in) investing activities

 

 i 8,167

 

 

 

( i 142

)

 

 

 

 

 

 

Cash flows from financing activities:

 

 

 

Proceeds from term loans

 

 i 250

 

 

 

-

 

Repayments of term loans

 

( i 1,250

)

 

 

( i 2,000

)

Proceeds from revolving credit facility

 

 i 2,795

 

 

 

 i 20,763

 

Repayments of revolving credit facility

 

( i 5,299

)

 

 

( i 18,563

)

Net cash (used in) provided by financing activities

 

( i 3,504

)

 

 

 i 200

 

 

 

 

 

 

 

Net increase (decrease) in cash, cash equivalents, and restricted cash

 

 i 4,616

 

 

 

( i 1,131

)

 

 

 

 

 

 

Cash, cash equivalents, and restricted cash, beginning of period

 

 i 49

 

 

 

 i 1,270

 

Cash, cash equivalents, and restricted cash, end of period

$

 i 4,665

 

 

$

 i 139

 

 

 

 

 

 

 

Supplemental disclosures:

 

 

 

Cash paid during the period for interest

$

 i 132

 

 

$

 i 256

 



 

 

 

 

 

 

 

 

 

 

See accompanying notes to these Condensed Consolidated Financial Statements.

4


 

SCOTT’S LIQUID GOLD-INC. & SUBSIDIARIES

Notes to Condensed Consolidated Financial Statements (Unaudited)

(in thousands, except per share data)

 i 

Note 1. Organization and Summary of Significant Accounting Policies

(a) Company Background

Scott’s Liquid Gold-Inc., a Colorado corporation was incorporated on February 15, 1954. Scott’s Liquid Gold-Inc. and its wholly-owned subsidiaries (collectively, the “Company,” “we,” “our,” or “us”) develop, market and sell high quality products. Our business is comprised of one segment, household products.

 i 

(b) Principles of Consolidation

Our Condensed Consolidated Financial Statements include our accounts and those of our wholly-owned subsidiaries. All intercompany accounts and transactions have been eliminated.

On September 15, 2023, we entered into and consummated a Stock Purchase Agreement (the “Stock Purchase Agreement”) with Neoteric Beauty Holdings, LLC, a Delaware limited liability company (the “Neoteric Buyer”), pursuant to which the Company agreed to sell  i 100% of the outstanding stock of Neoteric Cosmetics, Inc. (“Neoteric”) to the Neoteric Buyer. Neoteric owned and operated the Denorex®, Zincon®, and Neoteric Diabetic Skin Care® brands. We have reflected the operations of the Neoteric brands as discontinued operations for all periods presented. The Neoteric brands were previously classified under our health and beauty care products segment. See Note 3 for further information.

Effective June 30, 2023, we entered into, and in July 2023 we closed, a purchase agreement with a buyer, pursuant to which we agreed to sell all of our right, title and interest in and to certain assets of the Alpha® Skin Care brand (the "Alpha Purchase Agreement"). We have reflected the operations of the Alpha® Skin Care brand as discontinued operations for all periods presented. The Alpha product line was previously classified under our health and beauty care products segment. See Note 3 for further information.

Effective July 2023 we entered into, and in July 2023 closed, a purchase agreement with a buyer, pursuant to which we agreed to sell all of our right, title and interest in and to certain assets of the BIZ® brand. We have reflected the operations of the BIZ® brand as discontinued operations for all periods presented. The BIZ® product line was previously classified under our household products segment. See Note 3 for further information.

On January 23, 2023, we entered into an asset purchase agreement with a buyer, pursuant to which we agreed to sell all of our right, title and interest in and to certain assets of the Scott's Liquid Gold® brand, including the Wood Care and Floor Restore products. We have reflected the operations of the Scott's Liquid Gold® brand as discontinued operations for all periods presented, which was previously classified under our household products segment. See Note 3 for further information.

On December 15, 2022, we entered into an asset purchase agreement with a buyer, pursuant to which we agreed to sell all of our right, title and interest in and to certain assets of the Prell® product line. We have reflected the operations of the Prell® product line as discontinued operations for all periods presented, which was previously classified under our health and beauty care products segment. See Note 3 for further information.

 / 
 i 

(c) Basis of Presentation

The unaudited Condensed Consolidated Statements of Operations, Condensed Consolidated Balance Sheets, and Condensed Consolidated Statements of Cash Flows included in this Report have been prepared by the Company. In our opinion, all adjustments (which include only normal recurring adjustments) necessary to present fairly the financial position at September 30, 2023 and results of operations and cash flows for all periods have been made.

Certain information and footnote disclosures normally included in financial statements prepared in accordance with generally accepted accounting principles in the United States (“GAAP”) have been condensed or omitted pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”). These Condensed Consolidated Financial Statements should be read in conjunction with our financial statements and notes thereto included in our Annual Report on Form 10-K for the year ended December 31, 2022. The results of operations for the period ended September 30, 2023 are not necessarily indicative of the operating results for the full year and are unaudited. Certain prior year amounts have been reclassified to conform to the current period presentation.

5


 

 i 

(d) Use of Estimates

The preparation of financial statements in conformity with GAAP requires us to make estimates and assumptions that affect the reported amounts in our financial statements of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Significant estimates include, but are not limited to, the realization of deferred tax assets, reserves for slow moving and obsolete inventory, customer returns and allowances, intangible asset useful lives and amortization method, operating lease right-of-use assets and operating lease liabilities, and stock-based compensation. Actual results could differ from our estimates.

 i 

(e) Cash and Cash Equivalents

We consider all highly liquid investments purchased with an original maturity of three months or less at the date of acquisition to be cash equivalents.
 

 i 

 

September 30, 2023

 

 

December 31, 2022

 

Cash

$

 i 4,415

 

 

$

 i 49

 

Restricted Cash

 

 i 250

 

 

 

-

 

 

$

 i 4,665

 

 

$

 i 49

 

 / 
 / 
 i 

(f) Inventories Valuation and Reserves

Inventories can consist of raw materials and finished goods and are stated at the lower of cost (first-in, first-out method) or net realizable value, which is defined as the estimated selling price in the ordinary course of business, less reasonably predictable costs of completion, disposal, and transportation. We estimate an inventory reserve, which is generally not material to our financial statements, for slow moving and obsolete products and raw materials based upon, among other things, an assessment of historical and anticipated sales of our products. In the event that actual results differ from our estimates, the results of future periods may be impacted. Raw materials balance are sold to contract manufacturing partners based on production demand.

 i 

(g) Discontinued Operations

Disposal groups that meet the discontinued operations criteria by the Financial Accounting Standards Board Accounting Standards Codification (“ASC”) 205-20-45 are classified as discontinued operations and are excluded from continuing operations and segment results for all periods presented.

 i 

(h) Leases

Lease assets and lease liabilities are recognized at the commencement of an arrangement where it is determined at inception that a lease exists. Lease assets represent the right to use an underlying asset for the lease term, and lease liabilities represent the obligation to make lease payments arising from the lease. These assets and liabilities are initially recognized based on the present value of lease payments over the lease term calculated using our incremental borrowing rate generally applicable to the location of the lease asset, unless the implicit rate is readily determinable. Lease terms include options to extend or terminate the lease when it is reasonably certain that those options will be exercised.

Certain nonlease components, such as maintenance and other services provided by the lessor, are included in the valuation of the lease. Leases with an initial term of 12 months or less, which are not material to our financial statements, are not recorded on the balance sheet, and the expense for these short-term leases and for operating leases is recognized on a straight-line basis over the lease term. Lease agreements with lease and nonlease components are combined as a single lease component.

 i 

(i) Intangible Assets

Internal-use software costs recognized as an intangible asset relates to capitalizable costs of computer software obtained for internal-use as defined by ASC 350-40-30-1. All other internal-use software costs are expensed as incurred by the Company. Amortization will be recorded over the estimated useful life of the software once the software is ready for its intended use and placed into service. In the second quarter of 2022, our internal-use software was implemented for its intended use. The estimated useful life for internal-use software is  i five years and will be periodically reassessed based on considerations for obsolescence, technology, competition, and other economic factors.

 / 

6


 

 i 

(j) Financial Instruments

Financial instruments which potentially subject us to concentrations of credit risk include cash and cash equivalents, restricted cash, and accounts receivable. We maintain our cash balances in the form of money market deposits with financial institutions that we believe are creditworthy. Historically, we have maintained balances in various operating accounts in excess of federally insured limits. We establish an allowance for doubtful accounts, which is generally not material to our financial statements, based upon factors surrounding the credit risk of specific customers, historical trends and other information. We have  i no significant financial instruments with off-balance sheet risk of accounting loss, such as foreign exchange contracts, option contracts or other foreign currency hedging arrangements.

The recorded amounts for cash and cash equivalents, restricted cash, receivables, other current assets, accounts payable, and accrued expenses approximate fair value due to the short-term nature of these financial instruments.

 / 
 i 

(k) Income Taxes

Income taxes reflect the tax effects of transactions reported in the Condensed Consolidated Financial Statements and consist of taxes currently payable plus deferred income taxes related to certain income and expenses recognized in different periods for financial and income tax reporting purposes. Deferred income tax assets and liabilities are recognized for the future income tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective income tax bases. A valuation allowance is established when it is more-likely-than-not that some portion or all of a deferred tax asset will not be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the period in which related temporary differences become deductible. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled.

Taxes are reported based on tax positions that meet a more-likely-than-not standard and that are measured at the amount that is more-likely-than-not to be realized. Differences between financial and tax reporting which do not meet this threshold are required to be recorded as unrecognized tax benefits or expense. We classify penalty and interest expense related to income tax liabilities as an income tax expense. There are  i  i no /  significant interest and penalties recognized in the Condensed Consolidated Statements of Operations or accrued on the Condensed Consolidated Balance Sheets.

Income tax expense during interim periods is based on applying an estimated annual effective income tax rate to year-to-date income, plus any significant unusual or infrequently occurring items which are recorded in the interim period. The provision for income taxes for the three and nine months ended September 30, 2023 differs from the amount that would be provided by applying the statutory U.S. federal income tax rate of  i  i 21 / % to pre-tax income primarily due to valuation allowance. The effective tax rate for the nine months ended September 30, 2023 and 2022 was  i 0.2% and  i 0.7% respectively.

The computation of the annual estimated effective tax rate at each interim period requires certain estimates and significant judgment including, but not limited to, the expected operating income for the year, and permanent differences. The accounting estimates used to compute the provision for income taxes may change as new events occur, more experience is obtained, additional information becomes known or as the tax environment changes.

In assessing the need for a valuation allowance, management must determine that there will be sufficient taxable income to realize deferred tax assets. Based upon the historical and anticipated future losses, management has determined that the deferred tax assets do not meet the more-likely-than-not threshold for realizability. Accordingly, a valuation allowance has been recorded against the Company’s net deferred tax assets as of September 30, 2023 and December 31, 2022.

 / 
 i 

(l) Revenue Recognition

Our revenue recognition policy is significant because the amount and timing of revenue is a key component of our results of operations. Certain criteria are required to be met in order to recognize revenue. If these criteria are not met, then the associated revenue is deferred until it is met. When consideration is received in advance of the delivery of goods or services, a contract liability is recorded. Our revenue contracts are identified when purchase orders are received and accepted from customers and represent a single performance obligation to sell our products to a customer.

Net sales reflect the transaction prices for contracts, which include products shipped at selling list prices reduced by variable consideration. Variable consideration includes estimates for expected customer allowances, promotional programs for consumers, and sales returns. Based on our customer-by-customer history, our variable consideration estimates are generally accurate and subsequent adjustments are generally immaterial.

7


 

Variable consideration is primarily comprised of customer allowances. Customer allowances primarily include reserves for trade promotions to support price features, displays, slotting fees, and other merchandising of our products to our customers. Promotional programs for consumers primarily include coupons, rebates, and certain other promotional programs, and do not represent a significant portion of variable consideration. The costs of both customer allowances and promotional programs for consumers are estimated using either the expected value or most likely amount approach, depending on the nature of the allowance, using all reasonably available information, including our historical experience and current expectations. Customer allowances and promotional programs for consumers are reflected in the transaction price when sales are recorded. We may adjust our estimates based on actual results and consideration of other factors that cause allowances. In the event that actual results differ from our estimates, the results of future periods may be impacted.

Sales returns are generally not material to our financial statements, and do not comprise a significant portion of variable consideration. Estimates for sales returns are based on, among other things, an assessment of historical trends, information from customers, and anticipated returns related to current sales activity. These estimates are established in the period of sale and reduce our revenue in that period.

Sales are recorded at the time that control of the products is transferred to customers. In evaluating the timing of the transfer of control of products to customers, we consider several indicators, including significant risks and rewards of products, our right to payment, and the legal title of the products. Based on the assessment of control indicators, sales are generally recognized when products are delivered to customers.

We have also established an allowance for doubtful accounts. We estimate this allowance based upon, among other things, an assessment of the credit risk of specific customers and historical trends. We believe our allowance for doubtful accounts is adequate to absorb any losses which may arise. In the event that actual losses differ from our estimates, the results of future periods may be impacted.

 i 

Customer allowances for trade promotions and allowance for doubtful accounts are included in net accounts receivable on the Condensed Consolidated Balance Sheets and were as follows:

 

September 30, 2023

 

 

December 31, 2022

 

Trade promotions

$

 i 94

 

 

$

 i 361

 

Allowance for doubtful accounts

 

 i 14

 

 

 

 i 59

 

 

$

 i 108

 

 

$

 i 420

 

 / 
 / 
 i 

(m) Advertising Costs

We expense advertising costs as incurred.

 i 

(n) Stock-Based Compensation

We account for share based payments by recognizing compensation expense based upon the estimated fair value of the awards on the date of grant. We determine the estimated grant-date fair value of stock options with only service conditions using the Black-Scholes option pricing model. In order to calculate the fair value of the options, certain assumptions are made regarding the components of the model, including the estimated fair value of underlying common stock, risk-free interest rate, volatility, expected dividend yield, and expected option life. Changes to the assumptions could cause significant adjustments to the valuation. We recognize compensation costs ratably over the vesting period using the straight-line method, which approximates the service period.

The Company issues restricted stock unit ("RSUs") awards with restrictions that lapse upon the passage of time (service vesting) and satisfaction of market conditions targeted to our Company’s stock price. For those RSU awards with only service vesting, the Company recognizes compensation cost on a straight-line basis over the service period. For awards with both market and service conditions, the Company starts recognizing compensation cost over the requisite service period, with the effect of the market conditions reflected in the calculation of the award's fair value at grant date. The Company values awards with only service vesting requirements based on the grant date share price. The Company values awards with market and service conditions using a Monte Carlo simulation. The Company determines the requisite service period for awards with both market and service conditions based on the longer of the explicit service period and the derived service period. Stock awards that contain market vesting conditions are included in the computations of diluted EPS reflecting the average number of shares that would be issued based on the highest 30-day average market price during the reporting periods, if their effect is dilutive. If the condition is based on an average of market prices over some period of time, the corresponding average for the period is used.

8


 

 i 

(o) Operating Costs and Expenses Classification

Cost of sales includes costs associated with manufacturing and distribution including labor, materials, freight-in, purchasing and receiving, quality control, repairs, maintenance, and other indirect costs, as well as warehousing and distribution costs. We classify freight-out as selling expenses. Other selling expenses consist primarily of costs for sales and sales support personnel, brokerage commissions, and promotional costs. Freight-out costs included in selling expenses totaled $ i 75 and $ i 64 for the three months ended September 30, 2023 and 2022, respectively, and totaled $ i 157 and $ i 443 for the nine months ended September 30, 2023 and 2022, respectively.

General and administrative expenses consist primarily of wages and benefits associated with management and administrative support departments, business insurance costs, professional fees, office facility related expenses, and other general support costs.

 / 
 i 

(p) Supplier Finance Programs

In September 2022, the FASB issued ASU No. 2022-04, “Liabilities-Supplier Finance Programs (Subtopic 405-50): Disclosure of Supplier Finance Program Obligations.” This ASU requires a buyer that uses supplier finance programs to make annual disclosures about the programs’ key terms, the balance sheet presentation of related amounts, the confirmed amount outstanding at the end of the period and associated roll-forward information. The guidance was effective for the Company beginning on January 1, 2023, except for the roll-forward information, which is effective beginning on January 1, 2024. This guidance has not had and is not expected to have a material impact on the Company’s Condensed Consolidated Financial Statements.

During 2022, we entered into an agreement with a third-party financial institution and an agreement with an insurance agency which allows us to obtain extended payment terms for our insurance policies. The insurance policies can be canceled by the Company at any time with 10 days’ notice. The financial institution may cancel this agreement after providing 10 days’ notice if the Company does not pay any installment payment according to the terms of the agreement. We do not provide any forms of guarantees under these agreements. Payments of our obligations are included in cash flows from operating activities in the Condensed Consolidated Statements of Cash Flows. Outstanding confirmed amounts are $ i 0 and $ i 218 as of September 30, 2023 and December 31, 2022, respectively, which will be recognized on the Condensed Consolidated Financial Statements as payments are due.

 i 

(q) Recently Issued Accounting Standards

In October 2023, the Financial Accounting Standards Board (the “FASB”) issued Accounting Standards Update (“ASU”) No. 2023-06, “Disclosure Improvements-Codification Amendments in Response to the SEC’s Disclosure Update and Simplification Initiative.” This ASU modified the disclosure and presentation requirements of a variety of codification topics by aligning them with the SEC’s regulations. This guidance is effective for the Company no later than June 30, 2027 and is not expected to have a material impact on the Company’s Consolidated Financial Statements.

 / 
 / 
 i 

Note 2. Liquidity

Primarily due to a decline in net sales, disruption of our international sales to China, and increases in costs associated with the manufacture and distribution of our products, the Company has sustained significant losses from operations in several reporting periods since 2019. Absent any other action, the Company previously believed it would require additional liquidity to continue its operations over the next 12 months.

Due to the sales of our various brands as disclosed in Note 3 to the Condensed Consolidated Financial Statements, which generated $ i 6,396 of cash in the third quarter of 2023, we have fully repaid all long-term debt as of July 2023. While, absent any other actions, our operating activities are still expected to result in negative cash flows, we now expect to have enough liquidity to finance operations for the next 12 months. Management has recently implemented actions to reduce the Company’s operating expenses through asset sales, consolidation of vendors, and personnel reductions. To further reduce operating losses, the Company is considering additional various strategic actions including asset sales, obtaining additional debt or equity financing (potentially in conjunction with mergers or acquisitions), workforce reduction, deferring or eliminating certain capital expenditures, and further reduction of other operating expenses to ensure alignment with customer demand in order to address long-term liquidity needs and pursue its business plan. The Company expects that these strategic actions will further reduce expenses and provide required liquidity for ongoing operations.

 / 

9


 

 i 

Note 3. Divestitures

Neoteric Cosmetics, Inc.

On September 15, 2023, we entered into and consummated a Stock Purchase Agreement with Neoteric Beauty Holdings, LLC, a Delaware limited liability company, pursuant to which the Company agreed to sell  i 100% of the outstanding stock of Neoteric Cosmetics, Inc to the Neoteric Buyer. Neoteric owned and operated the Denorex®, Zincon®, and Neoteric Diabetic Skin Care® brands. The closing consideration paid to the Company was $ i 1,750, with an initial deposit of $ i 175 paid on September 5, 2023. The operations of the Neoteric brands have been classified as income from discontinued operations for all periods presented. As part of the Stock Purchase Agreement, we agreed to maintain at least $ i 250 in accounts at our primary bank for a period of nine months following closing which is designated as restricted cash on the Condensed Consolidated Balance Sheets. Concurrent with the entry into the Stock Purchase Agreement, the Company entered into a transition services agreement with the Neoteric Buyer where both parties would perform certain identified services related to the operations of the brands contemplated in the Stock Purchase Agreement.  i This transition services agreement has a term of  i 90 days which can be extended by the Neoteric Buyer for up to three additional  i 30 day periods or extended as consented by both parties.  / 

Alpha® Skin Care

Effective June 30, 2023, we entered into, and in July 2023 we closed, a purchase agreement with a buyer, pursuant to which we agreed to sell all of our right, title and interest in and to certain assets of the Alpha® Skin Care brand. The Company received payments of $ i 2,500 and $ i 200 in July 2023 and August 2023, respectively, representing total consideration for the sale of the Alpha Skin Care brand in the amount of $ i 2,700. The operations of Alpha® have been classified as income from discontinued operations for all periods presented. Concurrent with the entry into the Alpha® Purchase Agreement, the Company entered into a transition services agreement with the buyer where both parties would perform certain identified services related to the operations of the brands contemplated in the Alpha® Purchase Agreement.  i This transition services agreement has a term of  i 90 days which can be extended by the buyer for up to three additional  i 30 day periods or extended as consented by both parties. / 

BIZ®

Effective June 30, 2023, we entered into, and in July 2023 we closed, a purchase agreement with a buyer, pursuant to which we agreed to sell all of our right, title and interest in and to certain assets of the BIZ® brand. The transactions contemplated by the BIZ® Purchase Agreement were consummated on July 7, 2023. The total consideration paid to us was $ i 1,000, plus an amount equal to the value of the BIZ® inventory, valued at $ i 946 as of the effective date of the agreement, subject to post-close adjustment. The operations of BIZ® have been classified as income from discontinued operations for all periods presented. Concurrent with the entry into the BIZ® Purchase Agreement, the Company entered into a transition services agreement with the buyer where both parties would perform certain identified services related to the operations of the brands contemplated in the BIZ® Purchase Agreement.  i This transition services agreement has a term of  i 90 days which can be extended by the buyer for up to three additional  i 30 day periods or extended as consented by both parties. / 

Scott's Liquid Gold® Wood Care and Scott's Liquid Gold® Floor Restore

On January 23, 2023, we entered into an asset purchase agreement with a buyer, pursuant to which we agreed to sell all of our right, title and interest in and to certain assets of the Scott's Liquid Gold® Wood Care and Scott's Liquid Gold® Floor Restore product lines. The total consideration paid to us was $ i 800, plus an amount equal to the value of the Scott's Liquid Gold® Wood Care and Scott's Liquid Gold® Floor Restore inventory of $ i 1,136, subject to post-close adjustment. The Company may continue to use the name “Scott’s Liquid Gold” and “SLG” in a manner consistent with all past and current practices for a period of 1 year following the closing date of the asset purchase agreement, at which point the Company may only use the aforementioned names in connection with retaining records and other historical documentation. Concurrent with the entry into the asset purchase agreement, the Company entered into a transition services agreement with the buyer where both parties would perform certain identified services related to the operations of the brands contemplated in the asset purchase agreement. This transition services agreement concluded in accordance with the end of its term on July 22, 2023.

10


 

Additionally, the buyer will pay a royalty equal to  i 2% of gross sales for  i two years after the closing date (the "Scott's Liquid Gold® Royalty"). The Scott's Liquid Gold® Royalty resulted in recognition of a gain upon the sale of assets. Because the Scott's Liquid Gold® Royalty is variable consideration and is contingent on the outcome of future events that are largely outside of the Company’s control, the variable consideration from the Scott's Liquid Gold® Royalty was initially fully constrained and no amount was included in the results from discontinued operations. During the three months ended September 30, 2023, we assessed the variable consideration and concluded that the volatility of external factors continue to exist and, as a result, consideration for the Scott's Liquid Gold® Royalty continues to be recognized as received from the buyer. The constraint on the variable consideration will be reassessed at each subsequent reporting period. We have reflected the operations of the Scott's Liquid Gold® product lines as discontinued operations.

Prell®

On December 15, 2022, we entered into an asset purchase agreement with a buyer, pursuant to which we agreed to sell to all of our right, title and interest in and to certain assets of the Prell® product line. The total consideration paid to us was $ i 150, plus an amount equal to the value of the Prell® inventory of $ i 330, subject to post-close adjustment. Additionally, the buyer will pay a royalty equal to  i 3% of collections on net sales for four years after the closing date (the “Prell® Royalty”). The Prell® Royalty resulted in recognition of a gain upon the sale of assets. Because the Prell® Royalty is variable consideration and is contingent on the outcome of future events that are largely outside of the Company’s control, the variable consideration from the Prell® Royalty was initially fully constrained and no amount was included in the results from discontinued operations. During the three months ended September 30, 2023, we assessed the variable consideration and concluded that the volatility of external factors continue to exist and, as a result, consideration continues to be recognized as received from the buyer. The constraint on the variable consideration will be reassessed at each subsequent reporting period. We have reflected the operations of the Prell® product line as discontinued operations. Concurrent with the entry into the asset purchase agreement, the Company entered into a transition services agreement with the buyer where both parties would perform certain identified services related to the operations of the brands contemplated in the asset purchase agreement. This transition services agreement concluded in accordance with the end of its term on June 15, 2023.

Our Condensed Consolidated Balance Sheets and Condensed Consolidated Statements of Operations report discontinued operations separate from continuing operations. Our Condensed Consolidated Statements of Equity and Statements of Cash Flows combine the results of continuing and discontinued operations.  i A summary of financial information related to our discontinued operations is as follows:

11


 

Reconciliation of the Line Items Constituting Pretax Loss from Discontinued Operations to the After-Tax Loss from Discontinued Operations in the Condensed Consolidated Statements of Operations for the three and nine months ended September 30:

 

 

Three Months Ended September 30, 2023

 

 

Neoteric

 

 

Alpha®

 

 

BIZ®

 

 

Prell®

 

 

Scott's Liquid Gold®

 

 

Total

 

Net sales

$

 i 592

 

 

$

-

 

 

$

-

 

 

$

-

 

 

$

-

 

 

$

 i 592

 

Cost of sales

 

 i 318

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

 i 318

 

Gross profit

 

 i 274

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

 i 274

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Operating expenses:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Selling

 

 i 90

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

 i 90

 

General and administrative

 

 i 47

 

 

 

 i 13

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

 i 60

 

Intangible asset amortization

 

 i 4

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

 i 4

 

Operating income (loss) from discontinued operations

 

 i 133

 

 

 

( i 13

)

 

 

-

 

 

 

-

 

 

 

-

 

 

 

 i 120

 

Gain on sale of discontinued operations

 

 i 1,501

 

 

 

 i 1,585

 

 

 

 i 781

 

 

 

 

 

 

 

 

 

 i 3,867

 

Interest expense

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

Income from discontinued operations

$

 i 1,634

 

 

$

 i 1,572

 

 

$

 i 781

 

 

$

-

 

 

$

-

 

 

$

 i 3,987

 

 

 

Three Months Ended September 30, 2022

 

 

Neoteric

 

 

Alpha®

 

 

BIZ®

 

 

Prell®

 

 

Scott's Liquid Gold®

 

 

Total

 

Net sales

$

 i 494

 

 

$

 i 131

 

 

$

 i 1,179

 

 

$

 i 903

 

 

$

 i 837

 

 

$

 i 3,544

 

Cost of sales

 

 i 172

 

 

 

( i 18

)

 

 

 i 958

 

 

 

 i 540

 

 

 

 i 387

 

 

 

 i 2,039

 

Gross profit

 

 i 322

 

 

 

 i 149

 

 

 

 i 221

 

 

 

 i 363

 

 

 

 i 450

 

 

 

 i 1,505

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Operating expenses:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Selling

 

 i 108

 

 

 

 i 63

 

 

 

 i 384

 

 

 

 i 261

 

 

 

 i 192

 

 

 

 i 1,008

 

Intangible asset amortization

 

 i 4

 

 

 

-

 

 

 

 i 6

 

 

 

 i 12

 

 

 

-

 

 

 

 i 22

 

Operating income (loss) from discontinued operations

 

 i 210

 

 

 

 i 86

 

 

 

( i 169

)

 

 

 i 90

 

 

 

 i 258

 

 

 

 i 475

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Interest expense

 

-

 

 

 

-

 

 

 

( i 44

)

 

 

( i 14

)

 

 

( i 54

)

 

 

( i 112

)

Income (loss) from discontinued operations

$

 i 210

 

 

$

 i 86

 

 

$

( i 213

)

 

$

 i 76

 

 

$

 i 204

 

 

$

 i 363

 

 

 

Nine Months Ended September 30, 2023

 

 

Neoteric

 

 

Alpha®

 

 

BIZ®

 

 

Prell®

 

 

Scott's Liquid Gold®

 

 

Total

 

Net sales

$

 i 2,144

 

 

$

 i 879

 

 

$

 i 2,164

 

 

$

-

 

 

$

 i 187

 

 

$

 i 5,374

 

Cost of sales

 

 i 1,132

 

 

 

 i 278

 

 

 

 i 1,510

 

 

 

-

 

 

 

 i 95

 

 

 

 i 3,015

 

Gross profit

 

 i 1,012

 

 

 

 i 601

 

 

 

 i 654

 

 

 

-

 

 

 

 i 92

 

 

 

 i 2,359

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Operating expenses:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Selling

 

 i 342

 

 

 

 i 141

 

 

 

 i 437

 

 

 

-

 

 

 

 i 28

 

 

 

 i 948

 

General and administrative

 

 i 47

 

 

 

 i 22

 

 

 

 i 12

 

 

 

-

 

 

 

 i 22

 

 

 

 i 103

 

Intangible asset amortization

 

 i 14

 

 

 

-

 

 

 

 i 12

 

 

 

-

 

 

 

-

 

 

 

 i 26

 

Operating income from discontinued operations

 

 i 609

 

 

 

 i 438

 

 

 

 i 193

 

 

 

-

 

 

 

 i 42

 

 

 

 i 1,282

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Interest expense

 

-

 

 

 

-

 

 

 

( i 88

)

 

 

-

 

 

 

( i 18

)

 

 

( i 106

)

Gain on sale of discontinued operations

 

 i 1,501

 

 

 

 i 1,585

 

 

 

 i 781

 

 

 

-

 

 

 

 i 787

 

 

 

 i 4,654

 

Income from discontinued operations

$

 i 2,110

 

 

$

 i 2,023

 

 

$

 i 886

 

 

$

-

 

 

$

 i 811

 

 

$

 i 5,830

 

 

12


 

 

Nine Months Ended September 30, 2022

 

 

Neoteric

 

 

Alpha®

 

 

BIZ®

 

 

Prell®

 

 

Scott's Liquid Gold®

 

 

Total

 

Net sales

$

 i 1,906

 

 

$

 i 1,982

 

 

$

 i 3,602

 

 

$

 i 2,494

 

 

$

 i 3,150

 

 

$

 i 13,134

 

Cost of sales

 

 i 843

 

 

 

 i 659

 

 

 

 i 2,665

 

 

 

 i 1,506

 

 

 

 i 1,409

 

 

 

 i 7,082

 

Gross profit

 

 i 1,063

 

 

 

 i 1,323

 

 

 

 i 937

 

 

 

 i 988

 

 

 

 i 1,741

 

 

 

 i 6,052

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Operating expenses:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Selling

 

 i 374

 

 

 

 i 344

 

 

 

 i 1,061

 

 

 

 i 753

 

 

 

 i 681

 

 

 

 i 3,213

 

Intangible asset amortization

 

 i 15

 

 

 

-

 

 

 

 i 18

 

 

 

 i 36

 

 

 

-

 

 

 

 i 69

 

Operating income (loss) from discontinued operations

 

 i 674

 

 

 

 i 979

 

 

 

( i 142

)

 

 

 i 199

 

 

 

 i 1,060

 

 

 

 i 2,770

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Interest expense

 

-

 

 

 

-

 

 

 

( i 132

)

 

 

( i 42

)

 

 

( i 162

)

 

 

( i 336

)

Income (loss) from discontinued operations

$

 i 674

 

 

$

 i 979

 

 

$

( i 274

)

 

$

 i 157

 

 

$

 i 898

 

 

$

 i 2,434

 

There were  i  i no /  capital expenditures or significant operating and investing noncash items related to discontinued operations during the nine months ended September 30, 2023 and 2022, respectively.

Reconciliation of Major Classes of Assets of the Discontinued Operations to Amounts Presented Separately in the Consolidated Balance Sheets as of:
 

 

December 31, 2022

 

 

Neoteric®

 

 

Alpha®

 

 

BIZ®

 

 

Scott's Liquid Gold®

 

 

Total

 

Assets

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Current assets:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Inventories

$

 i 322

 

 

$

 i 1,268

 

 

$

 i 1,092

 

 

$

 i 1,235

 

 

$

 i 3,917

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Intangible assets, net

 

 i 113

 

 

 

-

 

 

 

 i 231

 

 

 

-

 

 

$

 i 344

 

Assets of discontinued operations

$

 i 435

 

 

$

 i 1,268

 

 

$

 i 1,323

 

 

$

 i 1,235

 

 

$

 i 4,261

 

There were  i no assets of discontinued operations related to Prell® in the above table. There were  i  i  i  i no /  /  /  assets of discontinued operations related to Prell®, Scott's Liquid Gold®, BIZ®, Alpha®, and Neoteric as of September 30, 2023.

The following summarizes the carrying values of assets and the resulting in the gain on sale of discontinued operations associated with Neoteric, Alpha®, BIZ®, and Scott's Liquid Gold® at the date of disposition:

 

 

Neoteric

 

 

Alpha®

 

 

BIZ®

 

 

Scott's Liquid Gold®

 

 

Total

 

Inventories

$

 i 150

 

 

$

 i 1,115

 

 

$

 i 946

 

 

$

 i 1,149

 

 

$

 i 3,360

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Trade names

 

 i 59

 

 

 

-

 

 

 

 i 145

 

 

 

-

 

 

 

 i 204

 

Formulas

 

 i 40

 

 

 

-

 

 

 

 i 71

 

 

 

-

 

 

 

 i 111

 

Non-compete agreement

 

-

 

 

 

-

 

 

 

 i 3

 

 

 

-

 

 

 

 i 3

 

Intangible assets, net

 

 i 99

 

 

 

-

 

 

 

 i 219

 

 

 

-

 

 

 

 i 318

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Proceeds from sale

 

 i 1,750

 

 

 

 i 2,700

 

 

 

 i 1,946

 

 

 

 i 1,936

 

 

 

 i 8,332

 

Gain on sale of discontinued operations

$

 i 1,501

 

 

$

 i 1,585

 

 

$

 i 781

 

 

$

 i 787

 

 

$

 i 4,654

 

 / 

 

 i 

Note 4. Stock-Based Compensation

On May 11, 2023, we granted  i 200,000 shares of restricted stock to two directors all of which vested on the grant date with a fair value of $ i 40.

On March 2, 2022, we granted  i 15,000 shares of restricted stock to one executive all of which vested on the grant date with a fair value of $ i 18.

13


 

On January 18, 2022, we granted  i 25,000 RSUs to an employee (the “2022 Individual Employee Grant”) with a grant date fair value of $ i 10.  i The 2022 Individual Employee Grant vested one-third on the initial grant date, and the remaining two-thirds will vest on each anniversary of the grant date.

Compensation cost related to stock options totaled $ i 0 and $ i 10 in the nine months ended September 30, 2023 and 2022, respectively. The stock options were fully vested in the second quarter of 2022. There was  i no tax benefit from recording the non-cash expense as it relates to the options granted to employees, as these were qualified stock options which are not normally tax deductible.

Compensation cost related to RSUs totaled $ i 58 and $ i 103 for the nine months ended September 30, 2023 and 2022, respectively. Approximately $ i 38 of total unrecognized compensation costs related to non-vested RSUs is expected to be recognized over the next  i three years.

 / 
 i 

Note 5. Earnings per Share

Per share data is determined by using the weighted average number of common shares outstanding. Common equivalent shares are considered only for diluted earnings per share, unless considered anti-dilutive. Common equivalent shares, determined using the treasury stock method, result from stock options with exercise prices that are below the average market price of the common stock.

Basic earnings per share include no dilution and are computed by dividing income available to common shareholders by the weighted-average number of shares outstanding during the period. Diluted earnings per share reflect the potential of securities that could share in our earnings.

 i 

A reconciliation of the weighted average number of common shares outstanding (in thousands) is as follows. The dilutive effect of stock options and RSUs is excluded for periods in which the impact is anti-dilutive and when the Company has a net loss because the impact is also anti-dilutive.

 

Three Months Ended September 30,

 

 

Nine Months Ended September 30,

 

 

2023

 

 

2022

 

 

2023

 

 

2022

 

Common shares outstanding, beginning of the period

 

 i 12,997

 

 

 

 i 12,749

 

 

 

 i 12,797

 

 

 

 i 12,727

 

Weighted average common shares issued

 

-

 

 

 

-

 

 

 

 i 104

 

 

 

 i 20

 

Weighted average number of common shares outstanding

 

 i 12,997

 

 

 

 i 12,749

 

 

 

 i 12,901

 

 

 

 i 12,747

 

Dilutive effect of common share equivalents

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

Diluted weighted average number of common shares outstanding

 

 i 12,997

 

 

 

 i 12,749

 

 

 

 i 12,901

 

 

 

 i 12,747

 

 / 

 

 i 

Common stock equivalents (in thousands) that have been excluded from the calculation of earnings per share because they would have been anti-dilutive are as follows:

 

 

Three Months and Nine Months Ended September 30,

 

 

2023

 

 

2022

 

Stock options

 

 i  i 56 / 

 

 

 

 i  i 153 / 

 

Restricted stock units

 

 i  i 20 / 

 

 

 

 i  i 88 / 

 

 / 
 / 

 

 i 

Note 6. Segment Information

We previously operated in  i two different segments: household products and health and beauty care products. We chose to organize our business around these segments based on differences in the products sold. Accounting policies for our segments were the same as those described in Note 1. We evaluated segment performance based on segment income or loss from operations.

In the third quarter of 2023, in conjunction with the divestitures brands, the Company determined it has  i one reportable segment. These divestitures are described in Note 3.

 / 

14


 

 i 

Note 7. Intangible Assets

 i 

Intangible assets, which are comprised of our capitalized costs of software obtained for internal-use, consisted of the following:

 

As of September 30, 2023

 

 

As of December 31, 2022

 

 

Gross Carrying Amount

 

 

Accumulated Amortization

 

 

Net Carrying Value

 

 

Gross Carrying Amount

 

 

Accumulated Amortization

 

 

Net Carrying Value

 

Internal-use software

 

 i 898

 

 

 

 i 240

 

 

 

 i 658

 

 

 

 i 898

 

 

 

 i 105

 

 

 

 i 793

 

 / 

Amortization expense for the three months ended September 30, 2023 and 2022 was $ i 45 and $ i 65, respectively. Amortization expense for the nine months ended September 30, 2023 and 2022 was $ i 135 and $ i 313, respectively.

 i 

Estimated amortization expense for 2023 and subsequent years is as follows:
 

Remainder of 2023

$

 i 45

 

2024

 

 i 180

 

2025

 

 i 180

 

2026

 

 i 180

 

2027

 

 i 73

 

Total

$

 i 658

 

 / 
 / 

 

 i 

Note 8. Long-Term Debt

UMB Loan Agreement

On July 1, 2020, we entered into a Loan and Security Agreement (as amended, the “UMB Loan Agreement”) with UMB Bank, N.A. Under the UMB Loan Agreement we obtained a $ i 3,000 term loan, with equal  i monthly payments fully amortized over  i three years which was repaid in full in the second quarter of 2022, and a revolving credit facility, with a maximum commitment of $ i 4,000 bearing interest at the  i one-month term SOFR rate +  i 6.83% with a floor of  i 7.75%.

The UMB Loan Agreement was terminated on  i February 27, 2023 and the revolving credit facility was paid in full on February 28, 2023. The loans were secured by all of the assets of the Company and its subsidiaries. Unamortized loan costs were $ i 0 and $ i 100 as of September 30, 2023 and December 31, 2022, respectively. Amortization of loan costs for the nine months ended September 30, 2023 was $ i 100, including $ i 83 that were expensed as a result of the termination of the UMB Loan Agreement. Amortization of loan costs for the nine months ended September 30, 2022 was $ i 99.

La Plata Loan Agreement

On November 9, 2021, we entered into a loan and security agreement (as amended, the “La Plata Loan Agreement”) with La Plata Capital, LLC (“La Plata”). Under the La Plata Loan Agreement, we obtained a $ i 2,000 term loan that bears interest at  i 14% and a $ i 250 term loan that bears interest at  i 15%. We repaid $ i 1,000 of principal against the La Plata Loan Agreement during the first quarter of 2022.

Unamortized loan costs were $ i 0 and $ i 20 as of September 30, 2023 and December 31, 2022, respectively. Amortization of loan costs for the nine months ended September 30, 2023 and 2022 were $ i 20 and $ i 26, respectively.

On July 7, 2023, the La Plata term loans were paid in full and the La Plata Loan Agreement was terminated.
 

 / 
 i 

Note 9. Leases

We have entered into a lease for our corporate headquarters with a remaining lease term of  i 7 years. This lease includes both lease and nonlease components, which are accounted for as a single lease component as we have elected the practical expedient to combine these components for all leases. As this lease does not provide an implicit rate, we calculated the right-of-use assets and lease liabilities using our secured incremental borrowing rate at the lease commencement date. We currently do not have any finance leases outstanding.

15


 

 i 

Information related to leases was as follows:

 

 

Three Months Ended September 30, 2023

 

Nine Months Ended September 30, 2023

 

Operating lease information:

 

 

 

 

Operating lease cost

$

 i 101

 

$

 i 304

 

Operating cash flows from operating leases

 

 i 101

 

 

 i 304

 

Net assets obtained in exchange for new operating lease liabilities

 

-

 

 

-

 

 

 

 

 

 

Weighted average remaining lease term in years

 

 i 7.17

 

 

 i 7.17

 

Weighted average discount rate

 

 i 5.1

%

 

 i 5.1

%

 

 

Three Months Ended September 30, 2022

 

Nine Months Ended September 30, 2022

 

Operating lease information:

 

 

 

 

Operating lease cost

$

 i 100

 

$

 i 200

 

Operating cash flows from operating leases

 

 i 100

 

 

 i 200

 

Net assets obtained in exchange for new operating lease liabilities

 

-

 

 

-

 

 

 

 

 

 

Weighted average remaining lease term in years

 

 i 8.17

 

 

 i 8.17

 

Weighted average discount rate

 

 i 5.1

%

 

 i 5.1

%

 / 
 i 

Future minimum annual lease payments are as follows:

 

Remainder of 2023

$

 i 102

 

2024

 

 i 413

 

2025

 

 i 420

 

2026

 

 i 427

 

2027

 

 i 434

 

Thereafter

 

 i 1,305

 

Total minimum lease payments

$

 i 3,101

 

Less imputed interest

 

( i 520

)

 

 

 

Total operating lease liability

$

 i 2,581

 

 / 
 / 

 

 

 

 i 

Note 10. Subsequent Events

Related Party Transactions

In October 2023, the Company agreed to reimburse Maran Capital Management, LLC ("Maran") $ i 200 for certain legal and other expenses incurred by Maran related to the Company between February 2021 and September 2023 and in consideration of the significant support received by the Company from Maran in sourcing, structuring, and negotiating the various asset divestitures aforementioned in Note 3 to the Condensed Consolidated Financial Statements.

 / 

16


 

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

Management’s Discussion and Analysis of Financial Condition and Results of Operations should be read in conjunction with the Company’s Consolidated Financial Statements in our Annual Report on Form 10-K for the year ended December 31, 2022. This Item 2 contains forward-looking statements. The matters discussed in these forward-looking statements are subject to risk, uncertainties, and other factors that could cause actual results to differ materially from those made, projected, or implied in the forward-looking statements. Please refer to "Item 1A. Risk Factors" in this Report and in our Annual Report on Form 10-K for the year ended December 31, 2022 for a discussion of the uncertainties, risks and assumptions associated with these statements.

Executive Overview

Our Business

Scott’s Liquid Gold-Inc. exists to positively impact consumers’ lives in the markets we serve while creating shareholder value. We have developed, marketed, and sold high-quality, high-value household products nationally and internationally to mass merchandisers, drugstores, supermarkets, hardware stores, e-commerce retailers, other retail outlets, and to wholesale distributors.

Primarily due to increases in costs associated with the manufacture and distribution of our products, the Company has experienced negative cash flows from operations for several reporting periods. In efforts to improve our financial position and liquidity, the Company has pursued asset sales of certain brands where management has determined that the brand(s) are not aligned with our long-term goals for growth and profitability.

The Company is considering a wide range of options, including one or more of the following: the sale of additional brands; a sale, merger, or other strategic transaction involving the entire company; acquisitions of other brands or companies; issuance of additional debt or equity; and continuing to operate as a public, independent company. We continue to operate our pet care brands, which is a product category we believe to have potential for organic or inorganic future growth opportunities.

Divestitures

On September 15, 2023, we entered into and consummated a Stock Purchase Agreement with a buyer to sell 100% of the outstanding stock of Neoteric. Effective June 30, 2023, and closed in July 2023, we sold the Alpha® Skin Care product line to a company that markets and distributes skin care products. Effective June 30, 2023, and closed in July 2023, we sold the BIZ® product line to a company that markets and distributes laundry products. On January 23, 2023, we sold the Scott's Liquid Gold® Wood Care and Scott's Liquid Gold® Floor Restore product lines to a company that markets and distributes wood care products. On December 15, 2022, we sold the Prell® brand to a company that markets and distributes natural hair and skincare products. We have reflected the operations of Alpha® Skin Care, BIZ®, Scott's Liquid Gold® and Prell® as discontinued operations for all periods presented.

See Note 3 - “Discontinued Operations and Assets Held for Sale” in the Notes to Condensed Consolidated Financial Statements for further information on the sale of these brands.

In conjunction with the sale of the Scott’s Liquid Gold® brand, as discussed below, the Company may continue to use names “Scott’s Liquid Gold” and “SLG” for up to one year following the closing date of the agreement on January 23, 2023. Following this transitional name period, the Company will only be able to use the aforementioned names in connection with retaining records and other historical or archived documents and any use required by or permitted as a fair use or otherwise under applicable law.

17


 

Results of Operations

Three months ended September 30, 2023 compared to three months ended September 30, 2022

 

 

Three Months Ended September 30, (in thousands)

 

 

 

 

 

 

 

 

Increase / (Decrease)

 

 

2023

 

 

2022

 

 

$

 

 

%

 

Net sales

$

907

 

 

$

733

 

 

$

174

 

 

 

23.7

%

Cost of sales

 

552

 

 

 

319

 

 

 

233

 

 

 

73.0

%

Gross profit

 

355

 

 

 

414

 

 

 

(59

)

 

 

(14.3

%)

Gross margin

 

39.1

%

 

 

56.5

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Operating expenses:

 

 

 

 

 

 

 

 

 

 

 

Advertising

 

89

 

 

 

166

 

 

 

(77

)

 

 

(46.4

%)

Selling

 

382

 

 

 

606

 

 

 

(224

)

 

 

(37.0

%)

General and administrative

 

811

 

 

 

655

 

 

 

156

 

 

 

23.8

%

Intangible asset amortization

 

45

 

 

 

65

 

 

 

(20

)

 

 

(30.8

%)

Total operating expenses

 

1,327

 

 

 

1,492

 

 

 

(165

)

 

 

(11.1

%)

Loss from operations

 

(972

)

 

 

(1,078

)

 

 

106

 

 

 

9.8

%

Interest expense

 

(32

)

 

 

(27

)

 

 

(5

)

 

 

(18.5

%)

Interest income

 

16

 

 

 

-

 

 

 

16

 

 

 

100.0

%

Loss before income taxes and discontinued operations

 

(988

)

 

 

(1,105

)

 

 

117

 

 

 

10.6

%

Income tax expense

 

(4

)

 

 

(2

)

 

 

(2

)

 

 

(100.0

%)

Loss from continuing operations

 

(992

)

 

 

(1,107

)

 

 

115

 

 

 

10.4

%

Income from discontinued operations

 

3,987

 

 

 

363

 

 

 

3,624

 

 

 

998.3

%

Net income (loss)

$

2,995

 

 

$

(744

)

 

$

3,739

 

 

 

502.6

%

Our operating results were primarily impacted by the following:

Increases in net sales and cost of sales are due to increased distribution of our products sold at existing and certain new customers. The decrease in gross profit and gross margin are primarily due to higher costs from our manufacturers and a change in the mix of our product sales to customers.
Decrease in advertising expenses is primarily due to a reduction in personnel costs related to the creation of advertising materials due to asset divestitures.
Decrease in selling expenses is primarily due to lower logistics and warehousing costs from a consolidation of our third-party logistics partners, and a reduction in personnel costs related to asset divestitures.
Increased general and administrative costs primarily due to increase in performance-related incentives for personnel and professional expenses related to strategic initiatives.
Decreased intangible asset amortization from reduced carrying amounts related to impairments recognized in 2022.
Results from discontinued operations, which are disclosed in Note 3 to the Condensed Consolidated Financial Statements.

18


 

Nine months ended September 30, 2023 compared to nine months ended September 30, 2022
 

 

Nine Months Ended September 30, (in thousands)

 

 

 

 

 

 

 

 

Increase / (Decrease)

 

 

2023

 

 

2022

 

 

$

 

 

%

 

Net sales

$

2,623

 

 

$

2,315

 

 

$

308

 

 

 

13.3

%

Cost of sales

 

1,564

 

 

 

1,255

 

 

 

309

 

 

 

24.6

%

Gross profit

 

1,059

 

 

 

1,060

 

 

 

(1

)

 

 

(0.1

%)

Gross margin

 

40.4

%

 

 

45.8

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Operating expenses:

 

 

 

 

 

 

 

 

 

 

 

Advertising

 

363

 

 

 

492

 

 

 

(129

)

 

 

(26.2

%)

Selling

 

1,276

 

 

 

2,326

 

 

 

(1,050

)

 

 

(45.1

%)

General and administrative

 

2,069

 

 

 

2,164

 

 

 

(95

)

 

 

(4.4

%)

Intangible asset amortization

 

135

 

 

 

313

 

 

 

(178

)

 

 

(56.9

%)

Impairment of goodwill and intangible assets

 

-

 

 

 

3,589

 

 

 

(3,589

)

 

 

(100.0

%)

Total operating expenses

 

3,843

 

 

 

8,884

 

 

 

(5,041

)

 

 

(56.7

%)

Loss from operations

 

(2,784

)

 

 

(7,824

)

 

 

5,040

 

 

 

64.4

%

Interest expense

 

(145

)

 

 

(83

)

 

 

(62

)

 

 

(74.7

%)

Interest income

 

16

 

 

 

-

 

 

 

16

 

 

 

100.0

%

Loss before income taxes and discontinued operations

 

(2,913

)

 

 

(7,907

)

 

 

4,994

 

 

 

63.2

%

Income tax expense

 

(6

)

 

 

(55

)

 

 

49

 

 

 

89.1

%

Loss from continuing operations

 

(2,919

)

 

 

(7,962

)

 

 

5,043

 

 

 

63.3

%

Income from discontinued operations

 

5,830

 

 

 

2,434

 

 

 

3,396

 

 

 

139.5

%

Net income (loss)

$

2,911

 

 

$

(5,528

)

 

$

8,439

 

 

 

152.7

%

Our operating results were primarily impacted by the following:

Increases in net sales and cost of sales are due to increased distribution of our products sold at existing and certain new customers. The decrease in gross profit and gross margin are primarily due to higher costs from our manufacturers and a change in the mix of our product sales to customers.
Decrease in advertising expenses is primarily due to a reduction in personnel costs related to the creation of advertising materials due to asset divestitures.
Decrease in selling expenses is primarily due to lower logistics and warehousing costs from a consolidation of our third-party logistics partners, and a reduction in personnel costs related to asset divestitures.
Decreased general and administrative costs primarily due to lower bank charges from the termination of our UMB Loan Agreement and reduced personnel costs, which are offset by performance-related incentives for personnel and professional expenses related to strategic initiatives.
Decreased intangible asset amortization from reduced carrying amounts related to impairments recognized in 2022.
Results from discontinued operations, which are disclosed in Note 3 to the Condensed Consolidated Financial Statements.

Liquidity and Capital Resources

Overview

Our primary sources of funds include cash from the sales of assets and cash from operating activities. Our principal uses of cash are to fund planned operating expenditures as well as historical debt paydown. Working capital movements are influenced by the sourcing of materials related to the production of products.

Financing Agreements

Please see Note 8 to our Condensed Consolidated Financial Statements for information on our La Plata Loan Agreement, which was satisfied and terminated in July 2023, and our UMB Loan Agreement, which was satisfied and terminated in February 2023.

19


 

Liquidity and Changes in Cash Flows

At September 30, 2023, we had approximately $4,665 in cash on hand, an increase of $4,616 from December 31, 2022.

The following is a summary of cash provided by or (used in) each of the indicated types of activities:

 

 

Nine Months Ended September 30, (in thousands)

 

 

 

 

 

 

 

 

Increase / (Decrease)

 

 

2023

 

 

2022

 

 

$

 

 

%

 

Operating activities

$

(47

)

 

$

(1,189

)

 

$

1,142

 

 

 

96.0

%

Investing activities

 

8,167

 

 

 

(142

)

 

 

8,309

 

 

 

5,851.4

%

Financing activities

 

(3,504

)

 

 

200

 

 

 

(3,704

)

 

 

(1,852.0

%)

Net cash used by operating activities was primarily related to conversion of working capital from accounts receivable and inventories.
Net cash provided by investing activities was due to the sale of our Scott's Liquid Gold®, Biz®, Alpha® Skin Care and Neoteric brands.
Net cash used in financing activities was from repayments and termination of our UMB and La Plata Loan Agreements.

The cash received from the sales of our BIZ® and Alpha® Skin Care brands in July 2023 was $3,700 and was partially used to pay off and terminate our La Plata Loan Agreement. Cash proceeds from the sale of Neoteric will be used to fund operations as we seek to grow our existing business or pursue other strategic transactions. While we believe that our current cash reserves represent sufficient cash to fund our operations, our liquidity has been affected by inflationary pressures at our customers which have caused sales decreases and higher costs on materials, logistics, and other purchases. We expect that our current cash reserves will be sufficient to meet operational cash needs during the next twelve months, but further economic impacts to our sales to customers or supply chain disruptions in the short-term could impact our liquidity.
 

ITEM 4. CONTROLS AND PROCEDURES

Disclosure Controls and Procedures

An evaluation was performed as of September 30, 2023, under the supervision and with the participation of our President and Chief Financial Officer, of the effectiveness of the design and operation of our disclosure controls and procedures (as such term is defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended). Based on that evaluation, our President and Chief Financial Officer concluded that our disclosure controls and procedures were not effective due to the previously disclosed material weakness in our internal controls resulting from our finance department not being able to process and account for complex, non-routine transactions in accordance with GAAP. Management concluded that we lack a sufficient number of trained professionals with technical accounting expertise to process and account for complex and non-routine transactions. We believe the actions described in the Company's Quarterly Report on Form 10-Q for the period ended June 30, 2023 will be sufficient to remediate the identified material weakness and related disclosure controls and procedures. However, we do not believe that the new and enhanced controls and procedures have been implemented for a sufficient amount of time for management to conclude that the material weakness in the Company’s internal controls over financial reporting and effectiveness of related disclosure controls and procedures has been fully remediated, and we are still in the process of improving those controls and procedures. We will continue to improve and monitor the effectiveness of these controls and will make any further changes that management determines to be appropriate.

Changes in Internal Control over Financial Reporting

There was no change in our internal control over financial reporting during the three months ended September 30, 2023 that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

20


 

PART II

 

ITEM 1A. RISK FACTORS

We have identified a material weakness in our internal control over financial reporting.

We are a public reporting company subject to the rules and regulations established from time to time by the SEC. As a public company we are required to document and test our internal control over financial reporting pursuant to Section 404 of the Sarbanes-Oxley Act so that our management can certify as to the effectiveness of our internal control over financial reporting.

As disclosed in Part I, Item 4, “Disclosure Controls and Procedures,” we have identified a material weakness in our controls related to our finance department lacking a sufficient number of trained professionals with technical accounting expertise to process and account for complex, non-routine transactions in accordance with GAAP as of June 30, 2023.

This material weakness did not result in any restatements to our Condensed Consolidated Financial Statements. Our management is committed to remediating this material weakness and is in the process of developing a remediation plan to address the material weakness.

In addition to the other information set forth in this Report, you should carefully consider the factors discussed in Item 1A, “Risk Factors” in the Company’s Annual Report on Form 10-K for the year ended December 31, 2022 and subsequent quarterly reports on Form 10-Q, which could materially affect our business, financial condition, or future results.

 

ITEM 6. EXHIBITS

Exhibit Number

Document

10.1

 

Stock Purchase Agreement, by and among the Company, Neoteric Cosmetics, Inc. and Neoteric Beauty Holdings, LLC dated September 15, 2023

31.1

Rule 13a-14(a) Certification of the President.

31.2

Rule 13a-14(a) Certification of the Chief Financial Officer.

32.1*

Section 1350 Certification.

101.INS

Inline XBRL Instance Document – the instance document does not appear in the Interactive Data File because XBRL tags are embedded within the Inline XBRL document.

101.SCH

Inline XBRL Taxonomy Extension Schema Document.

101.CAL

Inline XBRL Taxonomy Extension Calculation Linkbase Document.

101.LAB

Inline XBRL Taxonomy Extension Label Linkbase Document.

101.PRE

Inline XBRL Taxonomy Extension Presentation Linkbase Document.

101.DEF

 

Inline XBRL Taxonomy Extension Definition Linkbase Document.

104

 

Cover Page Interactive Data File (embedded within the Inline XBRL document)

 

 

* Furnished, not filed.

 

21


 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

SCOTT’S LIQUID GOLD-INC.

 

By:

/s/ Tisha Pedrazzini

Tisha Pedrazzini, President

(Principal Executive Officer)

 

 

By:

/s/ David M. Arndt

David M. Arndt, Chief Financial Officer

(Principal Financial and Chief Accounting Officer)

Date: November 7, 2023

22



Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘10-Q’ Filing    Date    Other Filings
6/30/27
1/1/24
12/31/23
Filed on:11/7/23
11/6/23
For Period end:9/30/23
9/15/238-K
9/5/23
7/22/23
7/7/238-K
6/30/2310-Q,  8-K
6/15/23
5/11/234
3/31/2310-Q
2/28/23
2/27/238-K
1/23/238-K
1/1/23
12/31/2210-K,  ARS
12/15/228-K
9/30/2210-Q
6/30/2210-Q
3/31/2210-K,  10-Q,  8-K
3/2/224
1/18/22
12/31/2110-K
11/9/214
7/1/208-K,  8-K/A
 List all Filings 


1 Subsequent Filing that References this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 3/26/24  Scott’s Liquid Gold - Inc.        10-K       12/31/23   76:9.3M                                   Donnelley … Solutions/FA
Top
Filing Submission 0000950170-23-060223   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Thu., May 16, 5:37:01.1pm ET